ArticleArthritis & rheumatology (Hoboken, N.J.)2026
Spondyloarthritis Preceding and Following Inflammatory Bowel Disease Diagnosis and Risk Factors: A Temporal Trends Analysis in a Population-Based Cohort.
Article in Arthritis & rheumatology (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveSpondyloarthritides (SpA) and inflammatory bowel disease (IBD) are immune-mediated diseases with overlap in clinical and immunologic features. However, temporal correlation of SpA and IBD in individual patients and risk factors are not well characterized.
methodsWe conducted a nationwide population-based study between January 1, 1998, and July 31, 2022, to determine SpA prevalence preceding IBD diagnosis and its incidence following IBD diagnosis. Using cross-linked register data, we identified individuals with IBD diagnosis and matched them to individuals without IBD. Using logistic regression, we determined the odds of SpA preceding IBD diagnosis, and using Cox regression, we determined the hazard of new-onset SpA following IBD diagnosis.
resultsOf 102,648 individuals included in the study, 17,108 (16.7%) individuals were diagnosed with IBD. The adjusted odds ratios of SpA in the eight-year period preceding IBD, Crohn disease (CD), and ulcerative colitis (UC) diagnosis, compared to matched individuals, were 1.95 (95% confidence interval [CI] 1.78-2.14), 2.84 (95% CI 2.43-3.32), and 1.61 (95% CI 1.43-1.81), respectively. The adjusted hazard ratios of SpA following IBD, CD, and UC diagnosis, compared to matched individuals, were 2.51 (95% CI 2.34-2.70), 3.17 (95% CI 2.81-3.59), and 2.24 (95% CI 2.05-2.45), respectively. SpA prevalence demonstrated temporal variability, with an increase during the few years around IBD diagnosis. Associations were stronger for axial SpA and among women and young adults following IBD diagnosis.
conclusionIn a population-based cohort, we report that SpA diagnosis is associated with IBD preceding and following its diagnosis. We demonstrate temporal variability and highlight clinical variables associated with SpA in IBD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.